Entity Details

Primary name RLBP1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP12271
EntryNameRLBP1_HUMAN
FullNameRetinaldehyde-binding protein 1
TaxID9606
Evidenceevidence at protein level
Length317
SequenceStatuscomplete
DateCreated1989-10-01
DateModified2021-06-02

Ontological Relatives

GenesRLBP1

GO terms

Show/Hide Table
GOName
GO:0001523 retinoid metabolic process
GO:0005502 11-cis retinal binding
GO:0005654 nucleoplasm
GO:0005813 centrosome
GO:0005829 cytosol
GO:0006776 vitamin A metabolic process
GO:0007601 visual perception
GO:0019841 retinol binding
GO:0044297 cell body
GO:0050896 response to stimulus
GO:1902936 phosphatidylinositol bisphosphate binding

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR001251 CRAL-TRIO lipid binding domainDomainDomain
IPR011074 CRAL/TRIO, N-terminal domainDomainDomain
IPR032941 Retinaldehyde-binding protein 1FamilyFamily
IPR036273 CRAL/TRIO, N-terminal domain superfamilyFamilyHomologous superfamily
IPR036865 CRAL-TRIO lipid binding domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607476 OMIMRod-cone dystrophy Newfoundland (NFRCD)A rod-cone dystrophy reminiscent of retinitis punctata albescens but with a substantially lower age at onset and more-rapid and distinctive progression. Rod-cone dystrophies results from initial loss of rod photoreceptors, later followed by cone photoreceptors loss. The disease is caused by variants affecting the gene represented in this entry.
607475 OMIMBothnia retinal dystrophy (BRD)A type of retinitis punctata albescens. Affected individuals show night blindness from early childhood with features consistent with retinitis punctata albescens and macular degeneration. The disease is caused by variants affecting the gene represented in this entry.
136880 OMIMRetinitis punctata albescens (RPA)A form of fleck retina disease characterized by aggregation of white flecks posteriorly in the retina, causing night blindness and delayed dark adaptation. It differs from fundus albipunctatus in being progressive and evolving to generalized atrophy of the retina. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00162 Vitamin ADrugbanksmall molecule

Interactions

4 interactions